Skip to main content
Erschienen in: Abdominal Radiology 5/2017

20.12.2016 | Pictorial Essay

Imaging patterns and focal lesions in fatty liver: a pictorial review

verfasst von: Sudhakar K. Venkatesh, Tiffany Hennedige, Geoffrey B. Johnson, David M. Hough, Joel G. Fletcher

Erschienen in: Abdominal Radiology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Non-alcoholic fatty liver disease is the most common cause of chronic liver disease and affects nearly one-third of US population. With the increasing trend of obesity in the population, associated fatty change in the liver will be a common feature observed in imaging studies. Fatty liver causes changes in liver parenchyma appearance on imaging modalities including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) and may affect the imaging characteristics of focal liver lesions (FLLs). The imaging characteristics of FLLs were classically described in a non-fatty liver. In addition, focal fatty change and focal fat sparing may also simulate FLLs. Knowledge of characteristic patterns of fatty change in the liver (diffuse, geographical, focal, subcapsular, and perivascular) and their impact on the detection and characterization of FLL is therefore important. In general, fatty change may improve detection of FLLs on MRI using fat suppression sequences, but may reduce sensitivity on a single-phase (portal venous) CT and conventional ultrasound. In patients with fatty liver, MRI is generally superior to ultrasound and CT for detection and characterization of FLL. In this pictorial essay, we describe the imaging patterns of fatty change in the liver and its effect on detection and characterization of FLLs on ultrasound, CT, MRI, and PET.
Literatur
1.
Zurück zum Zitat Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285CrossRef Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285CrossRef
2.
Zurück zum Zitat Boyce CJ, Pickhardt PJ, Kim DH, et al. (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194:623–628CrossRef Boyce CJ, Pickhardt PJ, Kim DH, et al. (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194:623–628CrossRef
3.
Zurück zum Zitat Ong JP, Elariny H, Collantes R, et al. (2005) Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 15:310–315CrossRef Ong JP, Elariny H, Collantes R, et al. (2005) Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 15:310–315CrossRef
4.
Zurück zum Zitat Paredes AH, Torres DM, Harrison SA (2012) Nonalcoholic fatty liver disease. Clin Liver Dis 16:397–419CrossRef Paredes AH, Torres DM, Harrison SA (2012) Nonalcoholic fatty liver disease. Clin Liver Dis 16:397–419CrossRef
5.
Zurück zum Zitat Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28:339–350CrossRef Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28:339–350CrossRef
6.
Zurück zum Zitat Younossi ZM, Stepanova M, Afendy M, et al. (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9:524–530 ((e521; quiz e560))CrossRef Younossi ZM, Stepanova M, Afendy M, et al. (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9:524–530 ((e521; quiz e560))CrossRef
7.
Zurück zum Zitat Hamaguchi M, Kojima T, Takeda N, et al. (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143:722–728CrossRef Hamaguchi M, Kojima T, Takeda N, et al. (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143:722–728CrossRef
8.
Zurück zum Zitat Hamer OW, Aguirre DA, Casola G, et al. (2006) Fatty liver: imaging patterns and pitfalls. Radiographics 26:1637–1653CrossRef Hamer OW, Aguirre DA, Casola G, et al. (2006) Fatty liver: imaging patterns and pitfalls. Radiographics 26:1637–1653CrossRef
9.
Zurück zum Zitat Wilson SR, Rosen IE, Chin-Sang HB, Arenson AM (1982) Fatty infiltration of the liver—an imaging challenge. J Can Assoc Radiol 33:227–232PubMed Wilson SR, Rosen IE, Chin-Sang HB, Arenson AM (1982) Fatty infiltration of the liver—an imaging challenge. J Can Assoc Radiol 33:227–232PubMed
10.
Zurück zum Zitat Bashist B, Hecht HL, Harley WD (1982) Computed tomographic demonstration of rapid changes in fatty infiltration of the liver. Radiology 142:691–692CrossRef Bashist B, Hecht HL, Harley WD (1982) Computed tomographic demonstration of rapid changes in fatty infiltration of the liver. Radiology 142:691–692CrossRef
11.
Zurück zum Zitat Brunt EM (2007) Pathology of fatty liver disease. Mod Pathol 20(Suppl 1):S40–S48CrossRef Brunt EM (2007) Pathology of fatty liver disease. Mod Pathol 20(Suppl 1):S40–S48CrossRef
12.
Zurück zum Zitat Quinn SF, Gosink BB (1985) Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol 145:753–755CrossRef Quinn SF, Gosink BB (1985) Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol 145:753–755CrossRef
13.
Zurück zum Zitat Onishi H, Theisen D, Dietrich O, Reiser MF, Zech CJ (2014) Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging. J Magn Reson Imaging 39:42–50CrossRef Onishi H, Theisen D, Dietrich O, Reiser MF, Zech CJ (2014) Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging. J Magn Reson Imaging 39:42–50CrossRef
14.
Zurück zum Zitat Schwenzer NF, Springer F, Schraml C, et al. (2009) Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51:433–445CrossRef Schwenzer NF, Springer F, Schraml C, et al. (2009) Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51:433–445CrossRef
15.
Zurück zum Zitat Fishbein M, Castro F, Cheruku S, et al. (2005) Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 39:619–625CrossRef Fishbein M, Castro F, Cheruku S, et al. (2005) Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 39:619–625CrossRef
16.
Zurück zum Zitat Needleman L, Kurtz AB, Rifkin MD, et al. (1986) Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol 146:1011–1015CrossRef Needleman L, Kurtz AB, Rifkin MD, et al. (1986) Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol 146:1011–1015CrossRef
17.
Zurück zum Zitat Strauss S, Gavish E, Gottlieb P, Katsnelson L (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 189:W320–W323CrossRef Strauss S, Gavish E, Gottlieb P, Katsnelson L (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 189:W320–W323CrossRef
18.
Zurück zum Zitat Sasso M, Beaugrand M, de Ledinghen V, et al. (2010) Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 36:1825–1835CrossRef Sasso M, Beaugrand M, de Ledinghen V, et al. (2010) Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 36:1825–1835CrossRef
19.
Zurück zum Zitat Limanond P, Raman SS, Lassman C, et al. (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230:276–280CrossRef Limanond P, Raman SS, Lassman C, et al. (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230:276–280CrossRef
20.
Zurück zum Zitat Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA (1980) Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137:727–729CrossRef Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA (1980) Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137:727–729CrossRef
21.
Zurück zum Zitat Ricci C, Longo R, Gioulis E, et al. (1997) Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 27:108–113CrossRef Ricci C, Longo R, Gioulis E, et al. (1997) Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 27:108–113CrossRef
22.
Zurück zum Zitat Johnston RJ, Stamm ER, Lewin JM, Hendrick RE, Archer PG (1998) Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements. Abdom Imaging 23:409–415CrossRef Johnston RJ, Stamm ER, Lewin JM, Hendrick RE, Archer PG (1998) Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements. Abdom Imaging 23:409–415CrossRef
23.
Zurück zum Zitat Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729–749CrossRef Reeder SB, Cruite I, Hamilton G, Sirlin CB (2011) Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 34:729–749CrossRef
24.
Zurück zum Zitat Yu H, McKenzie CA, Shimakawa A, et al. (2007) Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 26:1153–1161CrossRef Yu H, McKenzie CA, Shimakawa A, et al. (2007) Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 26:1153–1161CrossRef
25.
Zurück zum Zitat Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 36:1011–1014CrossRef Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 36:1011–1014CrossRef
26.
Zurück zum Zitat Cassidy FH, Yokoo T, Aganovic L, et al. (2009) Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 29:231–260CrossRef Cassidy FH, Yokoo T, Aganovic L, et al. (2009) Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 29:231–260CrossRef
27.
Zurück zum Zitat Yu H, Shimakawa A, McKenzie CA, et al. (2008) Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 60:1122–1134CrossRef Yu H, Shimakawa A, McKenzie CA, et al. (2008) Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 60:1122–1134CrossRef
28.
Zurück zum Zitat Yu H, Shimakawa A, Hines CD, et al. (2011) Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med 66:199–206CrossRef Yu H, Shimakawa A, Hines CD, et al. (2011) Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med 66:199–206CrossRef
29.
Zurück zum Zitat Décarie PO, Lepanto L, Billiard JS, et al. (2011) Fatty liver deposition and sparing: a pictorial review. Insights Imaging 2:533–538CrossRef Décarie PO, Lepanto L, Billiard JS, et al. (2011) Fatty liver deposition and sparing: a pictorial review. Insights Imaging 2:533–538CrossRef
30.
Zurück zum Zitat Hamer OW, Aguirre DA, Casola G, Sirlin CB (2005) Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology 237:159–169CrossRef Hamer OW, Aguirre DA, Casola G, Sirlin CB (2005) Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology 237:159–169CrossRef
31.
Zurück zum Zitat Kröncke TJ, Taupitz M, Kivelitz D, et al. (2000) Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging. Eur Radiol 10:1095–1100CrossRef Kröncke TJ, Taupitz M, Kivelitz D, et al. (2000) Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging. Eur Radiol 10:1095–1100CrossRef
32.
Zurück zum Zitat Sohn J, Siegelman E, Osiason A (2001) Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 176:471–474CrossRef Sohn J, Siegelman E, Osiason A (2001) Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. AJR Am J Roentgenol 176:471–474CrossRef
33.
Zurück zum Zitat Valls C, Iannacconne R, Alba E, et al. (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308CrossRef Valls C, Iannacconne R, Alba E, et al. (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308CrossRef
34.
Zurück zum Zitat Marin D, Iannaccone R, Catalano C, Passariello R (2006) Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images. J Magn Reson Imaging 24:690–694CrossRef Marin D, Iannaccone R, Catalano C, Passariello R (2006) Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images. J Magn Reson Imaging 24:690–694CrossRef
35.
Zurück zum Zitat Yeom SK, Byun JH, Kim HJ, et al. (2013) Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: quantitative and qualitative analysis. Magn Reson Imaging 31:911–917CrossRef Yeom SK, Byun JH, Kim HJ, et al. (2013) Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: quantitative and qualitative analysis. Magn Reson Imaging 31:911–917CrossRef
36.
Zurück zum Zitat Matsui O, Kadoya M, Takahashi S, et al. (1995) Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage. AJR Am J Roentgenol 164:1137–1140CrossRef Matsui O, Kadoya M, Takahashi S, et al. (1995) Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage. AJR Am J Roentgenol 164:1137–1140CrossRef
37.
Zurück zum Zitat Tom WW, Yeh BM, Cheng JC, et al. (2004) Hepatic pseudotumor due to nodular fatty sparing: the diagnostic role of opposed-phase MRI. AJR Am J Roentgenol 183:721–724CrossRef Tom WW, Yeh BM, Cheng JC, et al. (2004) Hepatic pseudotumor due to nodular fatty sparing: the diagnostic role of opposed-phase MRI. AJR Am J Roentgenol 183:721–724CrossRef
38.
Zurück zum Zitat Itai Y (2000) Peritumoral sparing of fatty liver: another important instance of focal sparing caused by a hepatic tumor. AJR Am J Roentgenol 174:868–870CrossRef Itai Y (2000) Peritumoral sparing of fatty liver: another important instance of focal sparing caused by a hepatic tumor. AJR Am J Roentgenol 174:868–870CrossRef
39.
Zurück zum Zitat Grossholz M, Terrier F, Rubbia L, et al. (1998) Focal sparing in the fatty liver as a sign of an adjacent space-occupying lesion. AJR Am J Roentgenol 171:1391–1395CrossRef Grossholz M, Terrier F, Rubbia L, et al. (1998) Focal sparing in the fatty liver as a sign of an adjacent space-occupying lesion. AJR Am J Roentgenol 171:1391–1395CrossRef
40.
Zurück zum Zitat Chung JJ, Kim MJ, Kim JH, Lee JT, Yoo HS (2003) Fat sparing of surrounding liver from metastasis in patients with fatty liver: MR imaging with histopathologic correlation. AJR Am J Roentgenol 180:1347–1350CrossRef Chung JJ, Kim MJ, Kim JH, Lee JT, Yoo HS (2003) Fat sparing of surrounding liver from metastasis in patients with fatty liver: MR imaging with histopathologic correlation. AJR Am J Roentgenol 180:1347–1350CrossRef
41.
Zurück zum Zitat Gabata T, Kadoya M, Matsui O, et al. (2001) Peritumoral spared area in fatty liver: correlation between opposed-phase gradient-echo MR imaging and CT arteriography. Abdom Imaging 26:384–389CrossRef Gabata T, Kadoya M, Matsui O, et al. (2001) Peritumoral spared area in fatty liver: correlation between opposed-phase gradient-echo MR imaging and CT arteriography. Abdom Imaging 26:384–389CrossRef
42.
Zurück zum Zitat Martí-Bonmatí L, Peñaloza F, Villarreal E, Martinez MJ (2005) Nonspecificity of the fat-sparing ring surrounding focal liver lesion at MR imaging. Acad Radiol 12:1551–1556CrossRef Martí-Bonmatí L, Peñaloza F, Villarreal E, Martinez MJ (2005) Nonspecificity of the fat-sparing ring surrounding focal liver lesion at MR imaging. Acad Radiol 12:1551–1556CrossRef
43.
Zurück zum Zitat Torres DM, Harrison SA (2012) Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. Semin Liver Dis 32:30–38CrossRef Torres DM, Harrison SA (2012) Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. Semin Liver Dis 32:30–38CrossRef
44.
Zurück zum Zitat Baffy G, Brunt EM, Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 56:1384–1391CrossRef Baffy G, Brunt EM, Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 56:1384–1391CrossRef
45.
Zurück zum Zitat Schütte K, Schulz C, Poranzke J, et al. (2014) Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver. BMC Gastroenterol 14:117CrossRef Schütte K, Schulz C, Poranzke J, et al. (2014) Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver. BMC Gastroenterol 14:117CrossRef
46.
Zurück zum Zitat van Kessel CS, Buckens CF, van den Bosch MA, et al. (2012) Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol 19:2805–2813CrossRef van Kessel CS, Buckens CF, van den Bosch MA, et al. (2012) Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol 19:2805–2813CrossRef
47.
Zurück zum Zitat Berger-Kulemann V, Schima W, Baroud S, et al. (2012) Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference. Eur J Surg Oncol 38:670–676CrossRef Berger-Kulemann V, Schima W, Baroud S, et al. (2012) Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference. Eur J Surg Oncol 38:670–676CrossRef
48.
Zurück zum Zitat Kulemann V, Schima W, Tamandl D, et al. (2011) Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol 79:e1–e6CrossRef Kulemann V, Schima W, Tamandl D, et al. (2011) Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol 79:e1–e6CrossRef
49.
Zurück zum Zitat Reiter MJ, Hannemann NP, Schwope RB, Lisanti CJ, Learn PA (2015) Role of imaging for patients with colorectal hepatic metastases: what the radiologist needs to know. Abdom Imaging 40:3029–3042CrossRef Reiter MJ, Hannemann NP, Schwope RB, Lisanti CJ, Learn PA (2015) Role of imaging for patients with colorectal hepatic metastases: what the radiologist needs to know. Abdom Imaging 40:3029–3042CrossRef
50.
Zurück zum Zitat Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics 31:1547–1568CrossRef Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics 31:1547–1568CrossRef
51.
Zurück zum Zitat Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177CrossRef Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177CrossRef
52.
Zurück zum Zitat Ronot M, Paradis V, Duran R, et al. (2013) MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol 23:914–923CrossRef Ronot M, Paradis V, Duran R, et al. (2013) MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol 23:914–923CrossRef
53.
Zurück zum Zitat Bioulac-Sage P, Rebouissou S, Thomas C, et al. (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748CrossRef Bioulac-Sage P, Rebouissou S, Thomas C, et al. (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748CrossRef
54.
Zurück zum Zitat Alexander J, Torbenson M, Wu TT, Yeh MM (2013) Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol 28:848–854CrossRef Alexander J, Torbenson M, Wu TT, Yeh MM (2013) Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol 28:848–854CrossRef
55.
Zurück zum Zitat Farges O, Ferreira N, Dokmak S, et al. (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85–89CrossRef Farges O, Ferreira N, Dokmak S, et al. (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85–89CrossRef
56.
Zurück zum Zitat Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN (2013) Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol 2013:604860CrossRef Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN (2013) Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol 2013:604860CrossRef
57.
Zurück zum Zitat Iannaccone R, Piacentini F, Murakami T, et al. (2007) Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243:422–430CrossRef Iannaccone R, Piacentini F, Murakami T, et al. (2007) Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243:422–430CrossRef
58.
Zurück zum Zitat Bruix J, Sherman M, Diseases AAftSoL (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRef Bruix J, Sherman M, Diseases AAftSoL (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRef
59.
Zurück zum Zitat Bruix J, Sherman M, Practice Guidelines Committee AeAftSoLD (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRef Bruix J, Sherman M, Practice Guidelines Committee AeAftSoLD (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRef
60.
Zurück zum Zitat Liver EAFTSOT, Cancer EOFRATO (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef Liver EAFTSOT, Cancer EOFRATO (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef
61.
Zurück zum Zitat Omata M, Lesmana LA, Tateishi R, et al. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474CrossRef Omata M, Lesmana LA, Tateishi R, et al. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474CrossRef
62.
Zurück zum Zitat Wu S, Tu R, Nan R, et al. (2016) Impact of variations in fatty liver on sonographic detection of focal hepatic lesions originally identified by CT. Ultrasonography 35:39–46CrossRef Wu S, Tu R, Nan R, et al. (2016) Impact of variations in fatty liver on sonographic detection of focal hepatic lesions originally identified by CT. Ultrasonography 35:39–46CrossRef
63.
Zurück zum Zitat Van Vledder MG, Boctor EM, Assumpcao LR, et al. (2010) Intra-operative ultrasound elasticity imaging for monitoring of hepatic tumour thermal ablation. HPB 12:717–723CrossRef Van Vledder MG, Boctor EM, Assumpcao LR, et al. (2010) Intra-operative ultrasound elasticity imaging for monitoring of hepatic tumour thermal ablation. HPB 12:717–723CrossRef
64.
Zurück zum Zitat Esensten ML, Shaw SL, Pak HY, Gildenhorn HL (1983) CT demonstration of multiple intraperitoneal teratomatous implants. J Comput Assist Tomogr 7:1117–1118CrossRef Esensten ML, Shaw SL, Pak HY, Gildenhorn HL (1983) CT demonstration of multiple intraperitoneal teratomatous implants. J Comput Assist Tomogr 7:1117–1118CrossRef
65.
Zurück zum Zitat Basaran C, Karcaaltincaba M, Akata D, et al. (2005) Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI. AJR Am J Roentgenol 184:1103–1110CrossRef Basaran C, Karcaaltincaba M, Akata D, et al. (2005) Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI. AJR Am J Roentgenol 184:1103–1110CrossRef
66.
Zurück zum Zitat Lin CY, Lin WY, Lin CC, et al. (2011) The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET. Clin Imaging 35:437–441CrossRef Lin CY, Lin WY, Lin CC, et al. (2011) The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET. Clin Imaging 35:437–441CrossRef
67.
Zurück zum Zitat Bural GG, Torigian DA, Burke A, et al. (2010) Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept. Mol Imaging Biol 12:233–239CrossRef Bural GG, Torigian DA, Burke A, et al. (2010) Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept. Mol Imaging Biol 12:233–239CrossRef
68.
Zurück zum Zitat Abele JT, Fung CI (2010) Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Radiology 254:917–924CrossRef Abele JT, Fung CI (2010) Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Radiology 254:917–924CrossRef
69.
Zurück zum Zitat Keramida G, Potts J, Bush J, et al. (2014) Accumulation of (18)F-FDG in the liver in hepatic steatosis. AJR Am J Roentgenol 203:643–648CrossRef Keramida G, Potts J, Bush J, et al. (2014) Accumulation of (18)F-FDG in the liver in hepatic steatosis. AJR Am J Roentgenol 203:643–648CrossRef
70.
Zurück zum Zitat Abikhzer G, Alabed YZ, Azoulay L, Assayag J, Rush C (2011) Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT. AJR Am J Roentgenol 196:176–180CrossRef Abikhzer G, Alabed YZ, Azoulay L, Assayag J, Rush C (2011) Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT. AJR Am J Roentgenol 196:176–180CrossRef
71.
72.
Zurück zum Zitat Kim YH, Kim JY, Jang SJ, et al. (2011) F-18 FDG uptake in focal fatty infiltration of liver mimicking hepatic malignancy on PET/CT images. Clin Nucl Med 36:1146–1148CrossRef Kim YH, Kim JY, Jang SJ, et al. (2011) F-18 FDG uptake in focal fatty infiltration of liver mimicking hepatic malignancy on PET/CT images. Clin Nucl Med 36:1146–1148CrossRef
73.
Zurück zum Zitat Le Y, Chen Y, Huang Z, Cai L, Zhang L (2014) Intense FDG activity in focal hepatic steatosis. Clin Nucl Med 39:669–672CrossRef Le Y, Chen Y, Huang Z, Cai L, Zhang L (2014) Intense FDG activity in focal hepatic steatosis. Clin Nucl Med 39:669–672CrossRef
74.
Zurück zum Zitat Harisankar CN (2014) Focal fat sparing of the liver: a nonmalignant cause of focal FDG uptake on FDG PET/CT. Clin Nucl Med 39:e359–e361PubMed Harisankar CN (2014) Focal fat sparing of the liver: a nonmalignant cause of focal FDG uptake on FDG PET/CT. Clin Nucl Med 39:e359–e361PubMed
75.
Zurück zum Zitat Purandare NC, Rangarajan V, Rajnish A, et al. (2008) Focal fat spared area in the liver masquerading as hepatic metastasis on F-18 FDG PET imaging. Clin Nucl Med 33:802–805CrossRef Purandare NC, Rangarajan V, Rajnish A, et al. (2008) Focal fat spared area in the liver masquerading as hepatic metastasis on F-18 FDG PET imaging. Clin Nucl Med 33:802–805CrossRef
76.
Zurück zum Zitat Han N, Feng H, Arnous MM, Bouhari A, Lan X (2016) Multiple liver focal fat sparing lesions with unexpectedly increased (18)F-FDG uptake mimicking metastases examined by ultrasound (18)F-FDG PET/CT and MRI. Hell J Nucl Med 19:173–175PubMed Han N, Feng H, Arnous MM, Bouhari A, Lan X (2016) Multiple liver focal fat sparing lesions with unexpectedly increased (18)F-FDG uptake mimicking metastases examined by ultrasound (18)F-FDG PET/CT and MRI. Hell J Nucl Med 19:173–175PubMed
77.
Zurück zum Zitat Lubezky N, Metser U, Geva R, et al. (2007) The role and limitations of 18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 11:472–478CrossRef Lubezky N, Metser U, Geva R, et al. (2007) The role and limitations of 18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. J Gastrointest Surg 11:472–478CrossRef
Metadaten
Titel
Imaging patterns and focal lesions in fatty liver: a pictorial review
verfasst von
Sudhakar K. Venkatesh
Tiffany Hennedige
Geoffrey B. Johnson
David M. Hough
Joel G. Fletcher
Publikationsdatum
20.12.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 5/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-1002-6

Weitere Artikel der Ausgabe 5/2017

Abdominal Radiology 5/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.